EAPA Case 7846:  Shari Pharmachem USA  (Notice of Determination as to Evasion, September 11, 2024)

EAPA Action: Notice of Determination as to Evasion for EAPA Case 7846 – Glycine

WASHINGTON – On September 11, 2024, CBP issued the notice of determination as to evasion for EAPA case 7846 against U.S. importer, Shari Pharmachem (USA) LLC (“Shari Pharmachem USA”) for evasion of the applicable AD/CVD orders A-570-836 and C-570-081 on glycine from China. Specifically, evidence on the record shows Shari Pharmachem USA imported Chinese-origin glycine that was transshipped through India, but did not declare them as subject to the aforementioned AD/CVD orders. As a result, the appropriate cash deposits were not applied to the merchandise at the time of entry. CBP has determined that there is substantial evidence of evasion of AD/CVD duties by Shari Pharmachem USA and, therefore, CBP issued a formal notice of determination as to evasion and has taken enforcement actions.

In light of CBP’s findings, CBP will:

• Suspend liquidation of any relevant unliquidated entries subject to this investigation;
• For any relevant entries that were extended, rate adjust and change to entry type 03 those entries subject to this investigation and suspend liquidation; and
• Reject any entry summaries and require a re-file for the aforementioned entries that are within the entry summary reject period.

For additional information on CBP and EAPA, please visit the EAPA Homepage. If you suspect an importer of duty evasion, CBP encourages you to submit an allegation through our online portal.

Follow CBP Office of Trade on X @CBPTradeGov.